Neovasc Company Profile (NASDAQ:NVCN)

About Neovasc

Neovasc logoNeovasc Inc. (Neovasc) is a specialty medical device company. The Company develops, manufactures and markets products for the cardiovascular marketplace. The Company's segment is the development, manufacture and marketing of medical devices. Its products include the Tiara technology in development for the transcatheter treatment of mitral valve disease, the Neovasc Reducer for the treatment of refractory angina, and tissue products. The Tiara is in preclinical/early clinical stage development to provide a minimally invasive transcatheter device for patients experiencing mitral regurgitation (MR) as a result of mitral heart valve disease. The Reducer is an hourglass-shaped, balloon-expandable, stainless steel, bare metal device, which is implanted in the coronary sinus, creating a restriction in venous outflow from the myocardium (the muscular layer of the heart wall). Neovasc produces Peripatch, a biological tissue product that is manufactured from pericardium.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Appliances & Equipment
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: NVCN
  • CUSIP:
Key Metrics:
  • Previous Close: $1.37
  • 50 Day Moving Average: $1.55
  • 200 Day Moving Average: $1.00
  • 52-Week Range: $0.37 - $4.68
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -5.11
  • P/E Growth: 0.00
  • Market Cap: $92.28M
  • Outstanding Shares: 66,866,000
  • Beta: -0.13
Profitability:
  • Net Margins: -1,423.84%
  • Return on Equity: -741.55%
  • Return on Assets: -68.95%
Debt:
  • Current Ratio: 0.32%
  • Quick Ratio: 0.31%
Additional Links:
Companies Related to Neovasc:

Analyst Ratings

Consensus Ratings for Neovasc (NASDAQ:NVCN) (?)
Ratings Breakdown: 1 Hold Rating, 2 Buy Ratings
Consensus Rating:Buy (Score: 2.67)
Consensus Price Target: $8.50 (515.94% upside)

Analysts' Ratings History for Neovasc (NASDAQ:NVCN)
Show:
DateFirmActionRatingPrice TargetDetails
12/27/2016Leerink SwannReiterated RatingOutperform$10.00View Rating Details
12/7/2016Ladenburg Thalmann Financial ServicesReiterated RatingNeutralView Rating Details
7/12/2016Canaccord GenuityReiterated RatingBuy$7.00View Rating Details
10/7/2015JMP SecuritiesInitiated CoverageOutperform$10.00View Rating Details
3/31/2015Northland SecuritiesInitiated CoverageOutperform$12.00View Rating Details
(Data available from 2/22/2015 forward)

Earnings

Earnings History for Neovasc (NASDAQ:NVCN)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/12/2015Q115($0.05)($0.10)$3.84 million$2.86 millionViewN/AView Earnings Details
3/30/2015Q414($0.06)($0.14)$3.31 million$3.35 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Neovasc (NASDAQ:NVCN)
Current Year EPS Consensus Estimate: $-1.48 EPS
Next Year EPS Consensus Estimate: $-0.27 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161($0.10)($0.10)($0.10)
Q2 20161($0.11)($0.11)($0.11)
Q3 20161($0.06)($0.06)($0.06)
Q4 20161($0.08)($0.08)($0.08)
Q1 20171($0.09)($0.09)($0.09)
Q2 20171($0.06)($0.06)($0.06)
Q3 20171($0.07)($0.07)($0.07)
Q4 20171($0.08)($0.08)($0.08)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Neovasc (NASDAQ:NVCN)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Neovasc (NASDAQ:NVCN)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Latest Headlines for Neovasc (NASDAQ:NVCN)
DateHeadline
News IconABR Of Neovasc Inc. (NASDAQ:NVCN) Stock At 2 - Stock Observer (NASDAQ:NVCN)
www.thestockobserver.com - February 17 at 4:35 PM
News IconVolatility Spiking as Shares Ride the Wave: Neovasc Inc. (NASDAQ:NVCN) - Aiken Advocate (NASDAQ:NVCN)
aikenadvocate.com - February 16 at 6:29 PM
News IconVolatility Spiking as Shares Ride the Wave: Neovasc Inc. (NASDAQ:NVCN) - Aiken Advocate (NASDAQ:NVCN)
aikenadvocate.com - February 16 at 6:29 PM
finance.yahoo.com logoNeovasc to Present at the Leerink Partners Global Healthcare Conference (NASDAQ:NVCN)
finance.yahoo.com - February 16 at 6:29 PM
News IconRange Watch on Technical Indicators for Neovasc Inc. (NVCN) - Davidson Register (NASDAQ:NVCN)
davidsonregister.com - February 10 at 7:51 PM
News IconTechnical Levels in View For Neovasc Inc. (NVCN) - Rives Journal (NASDAQ:NVCN)
rivesjournal.com - February 8 at 2:33 AM
News IconTrading Radar: Zooming in on Shares of Neovasc Inc. (NVCN) - Sherwood Daily (NASDAQ:NVCN)
sherwooddaily.com - February 4 at 5:47 AM
News IconAn Inside Look at Trading Hot Stocks: Neovasc Inc. (NVCN), Guess', Inc. (GES) - Post Analyst (NASDAQ:NVCN)
postanalyst.com - February 4 at 5:47 AM
News IconNeovasc Inc. (NASDAQ:NVCN) Quarterly growth Review - The Newburgh Press (NASDAQ:NVCN)
newburghpress.com - February 4 at 5:47 AM
News IconCat People Now Have A Reason To Watch The Westminster Dog Show (NASDAQ:NVCN)
mundoaguaysaneamiento.net - February 3 at 12:51 AM
News IconWhat are the Technical Charts Saying About Neovasc Inc. (NVCN) - Sherwood Daily (NASDAQ:NVCN)
sherwooddaily.com - February 2 at 1:04 AM
News IconNewsworthy Wonder Stock: Penny Stock Investors Looking at Neovasc Inc. (NASDAQ:NVCN) - Nelson Research (NASDAQ:NVCN)
nelsonobserver.com - February 1 at 6:19 AM
News IconStock ready to Pivot? Focus on Shares of Neovasc Inc. (NASDAQ:NVCN) - Prospect Journal (NASDAQ:NVCN)
prospectjournal.com - February 1 at 6:19 AM
News IconNeovasc Inc. (NASDAQ:NVCN) Stock ABR At 2 | Stock Observer - Stock Observer (NASDAQ:NVCN)
www.thestockobserver.com - January 28 at 5:17 AM
News IconStock Spotter: Review on Technical Levels for Neovasc Inc. (NVCN) - Sherwood Daily (NASDAQ:NVCN)
sherwooddaily.com - January 27 at 4:43 AM
News IconStock Seesawing as Volatility Sweeps in on Neovasc Inc. (NASDAQ:NVCN) - Wall Street Beacon (NASDAQ:NVCN)
wsbeacon.com - January 27 at 4:43 AM
News IconInvestors are Looking at Levels for Neovasc Inc. (NVCN) - Sherwood Daily (NASDAQ:NVCN)
sherwooddaily.com - January 25 at 10:06 PM
News IconEnlivened Volatility Spotted in Shares of Neovasc Inc. (NASDAQ:NVCN) - Wall Street Beacon (NASDAQ:NVCN)
wsbeacon.com - January 25 at 10:06 PM
News IconTechnical Indicator Review on Shares of Neovasc Inc. (NVCN) - Sherwood Daily (NASDAQ:NVCN)
sherwooddaily.com - January 25 at 5:45 AM
News IconIs Trouble Brewing For This Stock? Shares Gapping Lower: Neovasc Inc. (NASDAQ:NVCN) - Aiken Advocate (NASDAQ:NVCN)
aikenadvocate.com - January 25 at 5:45 AM
News IconInvestor Sphere: Keeping an Eye on Levels for Neovasc Inc. (NVCN) - Sherwood Daily (NASDAQ:NVCN)
sherwooddaily.com - January 24 at 12:15 AM
News IconPriming The Pump: Stock Volatility Spotted in Neovasc Inc. (NASDAQ:NVCN) - Wall Street Beacon (NASDAQ:NVCN)
wsbeacon.com - January 24 at 12:15 AM
News IconTrading Indicator Check on Neovasc Inc. (NVCN) - Sherwood Daily (NASDAQ:NVCN)
sherwooddaily.com - January 20 at 7:43 PM
smarteranalyst.com logoCompany Update (NASDAQ:NVCN): Neovasc Inc (US) Provides Update In Litigation With Medical Device Maker ... - Smarter Analyst (NASDAQ:NVCN)
www.smarteranalyst.com - January 20 at 7:43 PM
News IconStock ABR Neovasc Inc. (NASDAQ:NVCN) At 2 - Stock Observer (NASDAQ:NVCN)
www.thestockobserver.com - January 20 at 7:43 PM
News IconAmplified Volatility Spotted in Shares of Neovasc Inc. (NASDAQ:NVCN) - Wall Street Beacon (NASDAQ:NVCN)
wsbeacon.com - January 20 at 7:43 PM
News IconFocusing on the Charts for Neovasc Inc. (NVCN) - Sherwood Daily (NASDAQ:NVCN)
sherwooddaily.com - January 19 at 11:27 PM
News IconStock Review: ADX, MA, RSI Numbers in View for Neovasc Inc. (NVCN) - Sherwood Daily (NASDAQ:NVCN)
sherwooddaily.com - January 19 at 5:35 AM
News IconPumping the Brakes as Stock Dragged Lower Mid-Session: Neovasc Inc. (NASDAQ:NVCN) - Wall Street Beacon (NASDAQ:NVCN)
wsbeacon.com - January 19 at 5:35 AM
News IconIs Now the Time to Capitalize on Neovasc Inc. (NASDAQ:NVCN) - Prospect Journal (NASDAQ:NVCN)
prospectjournal.com - January 19 at 5:35 AM
streetinsider.com logoNeovasc (NVCN) Offers Update in Litigation with CardiAQ - StreetInsider.com (NASDAQ:NVCN)
www.streetinsider.com - January 19 at 5:35 AM
streetinsider.com logoNeovasc (NVCN) Offers Update in Litigation with CardiAQ (NASDAQ:NVCN)
www.streetinsider.com - January 18 at 7:31 PM
us.rd.yahoo.com logo2:07 pm Neovasc updates in its ongoing litigation with CardiAQ Valve Technologies (NASDAQ:NVCN)
us.rd.yahoo.com - January 18 at 7:31 PM
News IconCCI, MA, and RSI in Focus for Neovasc Inc. (NVCN) - Sherwood Daily (NASDAQ:NVCN)
sherwooddaily.com - January 17 at 7:19 PM
News IconCan This Stock Hit on All Cylinders And Achieve Projections: Neovasc Inc. (NASDAQ:NVCN) - Prospect Journal (NASDAQ:NVCN)
prospectjournal.com - January 9 at 7:39 PM
News IconCalling all Bargain Hunters: Stock Update on Neovasc Inc. (NASDAQ:NVCN) - Prospect Journal (NASDAQ:NVCN)
prospectjournal.com - January 9 at 7:39 PM
News IconStock ABR Of Neovasc Inc. (NASDAQ:NVCN) At 2 | Stock Observer - Stock Observer (NASDAQ:NVCN)
www.thestockobserver.com - January 7 at 12:38 AM
News IconAre Cagey Traders Interested in These Shares: Neovasc Inc ... - Prospect Journal (NASDAQ:NVCN)
prospectjournal.com - January 6 at 3:37 AM
4-traders.com logoResMed : Research Reports Initiation on Medical Equipment Stocks -- Stryker, Neovasc, Amedica, and ResMed (NASDAQ:NVCN)
www.4-traders.com - January 5 at 10:37 PM
News IconAnalysts Projecting Upside, Can This Stock Surge Higher: Neovasc Inc. (NASDAQ:NVCN) - Prospect Journal (NASDAQ:NVCN)
prospectjournal.com - January 2 at 6:48 PM
News IconNeovasc Inc (US) (NASDAQ:NVCN) Should Strengthen Further Into 2017 - Insider Financial (NASDAQ:NVCN)
www.insiderfinancial.com - December 30 at 8:50 AM
News IconUFC 207 will be Mike Goldberg's final event as a UFC commentator (NASDAQ:NVCN)
vouxmagazine.com - December 28 at 11:51 PM
News IconSmall Cap Concentration on Neovasc Inc. (NASDAQ:NVCN) - Prospect Journal (NASDAQ:NVCN)
prospectjournal.com - December 27 at 6:48 PM
News IconStacked Bid Presents Top Penny Stocks to Watch out for in 2017 (NASDAQ:NVCN)
www.usfinancialnewstoday.com - December 27 at 9:59 AM
wallstrt24.com logoTraders Watch list Neovasc Inc (US) (NASDAQ:NVCN), NorthStar Asset Administration Group Inc (NYSE:NSAM) - Wall Street 24 (NASDAQ:NVCN)
wallstrt24.com - December 26 at 6:21 PM
streetinsider.com logoNeovasc (NVCN) Confirms Judgement Stayed in CardiAQ Case; to Deposit $70M in Escrow (NASDAQ:NVCN)
www.streetinsider.com - December 23 at 7:06 PM
us.rd.yahoo.com logoNeovasc Announces Update in Litigation with CardiAQ (NASDAQ:NVCN)
us.rd.yahoo.com - December 23 at 7:06 PM
News IconShould You Buy Neovasc Inc. (NVCN) On Current Analyst Views? (NASDAQ:NVCN)
www.xboxonezone.com - December 22 at 7:41 AM
News IconTrump sent wind farm complaints to Scottish first minister (NASDAQ:NVCN)
vouxmagazine.com - December 22 at 12:47 AM
News IconRetirement Systems of Alabama Raises Position in Valley National Bancorp (VLY) (NASDAQ:NVCN)
myhealthbowl.com - December 22 at 12:47 AM

Social

What is Neovasc's stock symbol?

Neovasc trades on the NASDAQ under the ticker symbol "NVCN."

Where is Neovasc's stock going? Where will Neovasc's stock price be in 2017?

3 brokers have issued 1-year price objectives for Neovasc's stock. Their predictions range from $7.00 to $10.00. On average, they anticipate Neovasc's share price to reach $8.50 in the next year.

What are analysts saying about Neovasc stock?

Here are some recent quotes from research analysts about Neovasc stock:

  • According to Zacks Investment Research, "Neovasc Inc. is a specialty medical device company. It develops, manufactures and markets products for the cardiovascular marketplace. The Company's products include the Tiara (TM) mitral valve prosthesis in development for the transcatheter treatment of mitral valve disease, the Neovasc Reducer (TM) for the treatment of refractory angina and a line of advanced biological tissue products that are used as key components in third-party medical products, including transcatheter heart valves. Neovasc Inc. is headquartered in Richmond, Canada. " (1/12/2017)

  • Canaccord Genuity analysts commented, "We reiterate our BUY rating on NVCN, which we continue to see as an attractive long- term asset in the potentially huge Transcatheter mitral valve replacement (TMVR) space, about which we remain bullish long term. Granted, significant clinical and market development hurdles remain for all aspiring TMVR players, and enrollment in NVCN’s TIARA-1 feasibility trial is progressing slower than hoped (only 1 implant occurred in Q4). That said, FDA approval of the 40mm TIARA valve, granted in mid-January, should drive acceleration in enrollment, with multiple patients currently scheduled to receive implants over the next several weeks. We remind investors of positive results seen in the early feasibility trial, which gives us confidence in the TIARA platform." (3/30/2016)

Who owns Neovasc stock?

Neovasc's stock is owned by many different of retail and institutional investors. Top institutional investors include FMR LLC (3.89%), West Family Investments Inc. (2.99%) and Alyeska Investment Group L.P. (0.77%).

Who sold Neovasc stock? Who is selling Neovasc stock?

Neovasc's stock was sold by a variety of institutional investors in the last quarter, including FMR LLC.

Who bought Neovasc stock? Who is buying Neovasc stock?

Neovasc's stock was acquired by a variety of institutional investors in the last quarter, including West Family Investments Inc. and Alyeska Investment Group L.P..

How do I buy Neovasc stock?

Shares of Neovasc can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Neovasc stock cost?

One share of Neovasc stock can currently be purchased for approximately $1.38.

Neovasc (NASDAQ:NVCN) Chart for Wednesday, February, 22, 2017


Institutional Ownership Chart

Institutional Ownership by Quarter for Neovasc (NASDAQ:NVCN)

Earnings History Chart

Earnings by Quarter for Neovasc (NASDAQ:NVCN)

Dividend History Chart

Dividend Payments by Quarter for Neovasc (NASDAQ:NVCN)

Last Updated on 2/22/2017 by MarketBeat.com Staff